In vitro characterization of a lifetime-based activatable photoacoustic probe
暂无分享,去创建一个
Shai Ashkenazi | Qi Shao | Michael L. Wilson | Ekaterina Morgounova | Benjamin J. Hackel | Sadie M. Johnson
[1] Zhixing Xie,et al. In vitro testing of a protease-sensitive contrast agent for optoacoustic imaging. , 2010, Journal of biomedical optics.
[2] Ella F Jones,et al. Activatable Optical Probes for the Detection of Enzymes. , 2011, Current organic synthesis.
[3] Te-Jen Ma,et al. Design, synthesis, and imaging of an activatable photoacoustic probe. , 2010, Journal of the American Chemical Society.
[4] Shai Ashkenazi,et al. Lifetime-based photoacoustic probe activation modeled by a dual methylene blue-lysine conjugate , 2014, Photonics West - Biomedical Optics.
[5] M. Sudol,et al. The importance of being proline: the interaction of proline‐rich motifs in signaling proteins with their cognate domains , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] Shai Ashkenazi,et al. Photoacoustic lifetime contrast between methylene blue monomers and self-quenched dimers as a model for dual-labeled activatable probes , 2013, Journal of biomedical optics.
[7] Sanjiv S. Gambhir,et al. Activatable oligomerizable imaging agents for photoacoustic imaging of furin-like activity in living subjects. , 2013, Journal of the American Chemical Society.
[8] J. Quigley,et al. Matrix metalloproteinases and tumor metastasis , 2006, Cancer and Metastasis Reviews.
[9] Sanjiv Sam Gambhir,et al. Molecular Photoacoustic Imaging of Follicular Thyroid Carcinoma , 2013, Clinical Cancer Research.
[10] M. Stearns,et al. Evidence for increased activated metalloproteinase 2 (MMP-2a) expression associated with human prostate cancer progression. , 1996, Oncology research.
[11] Shai Ashkenazi,et al. Photoacoustic lifetime imaging of dissolved oxygen using methylene blue. , 2010, Journal of biomedical optics.
[12] B. T. Cox,et al. The challenges for quantitative photoacoustic imaging , 2009, BiOS.
[13] C. Gialeli,et al. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting , 2011, The FEBS journal.
[14] K. Nicolay,et al. Tumor Targeting of MMP-2/9 Activatable Cell-Penetrating Imaging Probes Is Caused by Tumor-Independent Activation , 2011, The Journal of Nuclear Medicine.
[15] L. Matrisian,et al. Matrix metalloproteinases: multifunctional contributors to tumor progression. , 2000, Molecular medicine today.
[16] Vasilis Ntziachristos,et al. Multispectral Optoacoustic Tomography of Matrix Metalloproteinase Activity in Vulnerable Human Carotid Plaques , 2011, Molecular Imaging and Biology.
[17] Sanjay Tyagi,et al. Molecular Beacons: Probes that Fluoresce upon Hybridization , 1996, Nature Biotechnology.
[18] Roger Y Tsien,et al. Tumor imaging by means of proteolytic activation of cell-penetrating peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[19] Dominique Trudel,et al. An immunohistochemical study , 2013 .